| 研究生: |
阮氏金梅 Nguyen, Thi-Kim-Mai |
|---|---|
| 論文名稱: |
基質貼附強度對腫瘤細胞球轉移之影響 Investigation on the effect of matrix adhesion strength in the metastatic pattern of tumor spheroid invasion |
| 指導教授: |
涂庭源
Tu, Ting-Yuan |
| 學位類別: |
碩士 Master |
| 系所名稱: |
工學院 - 生物醫學工程學系 Department of BioMedical Engineering |
| 論文出版年: | 2020 |
| 畢業學年度: | 108 |
| 語文別: | 英文 |
| 論文頁數: | 68 |
| 外文關鍵詞: | multicellular tumor spheroids, matrix-substrate interfacial adhesion strength, substrate stiffness, myosin II, matrix metalloproteinase |
| 相關次數: | 點閱:86 下載:0 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
The main threat and the reason for most cancer deaths are metastases. During the metastasis, invasion of cancer cells plays an important role that leads to the development of malignancy. To understand the specific patterns of tumor invasion and migration, as well as the relationship between cells, extracellular matrix (ECM) and substrate, engineered surfaces that not only can control the mechanical properties of the ECM structural but also can regulate cell adhesion, morphology, migration and other processes germane to cancer metastasis.
Thus, this study aims to establish both experimental and computation model for three-dimensional (3D) multicellular tumor spheroids (MCTS) invasive hydrogel platform for studying cell migration at matrix-substrate interface (MSI). This platform can be used to understand the specific patterns of tumor invasion and migration, as well as the relationship between cells and ECM and substrate.
Several cancer cell lines were grown into MCTS prior to embedding into collagen type I with concentration 2 mg/ml. Glass coverslip and a series of polydimethylsiloxane (PDMS) substrate membrane with different base/curing agent mass ratios were used to explore the effect substrate stiffness on MCTS invasion process, whose base/agent mass ratios were 10:1 and 30:1 (w:w). Besides, to investigate the effect of matrix-substrate interfacial adhesion strength (MSIAS), the MCTS-collagen mixture was then put onto PDMS (10:1) substrate, where the surface modification was performed using Poly-D-Lysine (PDL), glutaraldehyde (GA) and pluronic. Blebbistatin 10 µM and PD166793 10 µM were used to inhibit myosin II and matrix metalloproteinase (MMPs), respectively, after 3 hours of embedded MCTS into collagen. Migration of MTS invading ECM at MSI was observed for 24 hours through time-lapse imaging.
After examining the behavior and migration of several MCTSs formed from different cell lines on a non-coating glass substrate, MDA-MB-231 MTCS has the most obvious different character compared to other MTCS. Therefore, the investigation on the effect of matrix-substrate adhesion strength in the metastatic pattern of MCTS invasion at the heterogeneous interfaces in this study would be focused on the breast cancer cell line MDA-MB-231.
The MDA-MB-231 MCTSs had a movement speed on a stiff surface that was faster than a soft surface. MCTS tended to move in collective mode and spread according to the mechanism which was that the cells at the border of the MCTS that sensed the stiffness and movement dragged the cells at the core and became a conical spreading with a hollow bottom.
The differences in the extent of the spread, the invasion, and the migration mode of the MDA-MB-231 MCTSs were significantly different between the coatings. MCTSs were more invasive where MSIS is lower, and conversely, the rate of spreading is slower than where MSIS is high. In the case that has no influence on the substrate surface (pluronic coating), the metastatic behavior of MCTS is made easier because many single cells separate and move further.
Myosin II and MMPs are two important factors that help cells move in ECM. However, the results showed that MDA-MB-231 MCTS movement in ECM is mainly due to the contraction activity of myosin II.
By establishing this experimental and computational model, this study has the opportunity to identify salient patterns for this type of matrix-interface migration for cancer. The mechanics view may shed light on prevention of early metastasis.
[1] L. A. Dudjak, “Cancer metastasis,” Semin. Oncol. Nurs., vol. 8, no. 1, pp. 40–50, 1992.
[2] International Agency for Research on Cancer, “Latest global cancer data,” Asian Pacific Journal of Cancer Prevention, 2018. .
[3] J. Fares, M. Y. Fares, H. H. Khachfe, H. A. Salhab, and Y. Fares, “Molecular principles of metastasis: a hallmark of cancer revisited,” Signal Transduct. Target. Ther., vol. 5, no. 1, 2020.
[4] J. L. Albritton and J. S. Miller, “3D bioprinting: Improving in vitro models of metastasis with heterogeneous tumor microenvironments,” DMM Dis. Model. Mech., vol. 10, no. 1, pp. 3–14, 2017.
[5] H. Liu, T. Lu, G. J. Kremers, A. L. B. Seynhaeve, and T. L. M. Ten Hagen, “A microcarrier-based spheroid 3D invasion assay to monitor dynamic cell movement in extracellular matrix,” Biol. Proced. Online, vol. 22, no. 1, pp. 1–12, 2020.
[6] M. Lintz, A. Muñoz, and C. A. Reinhart-King, “The mechanics of single cell and collective migration of tumor cells,” J. Biomech. Eng., vol. 139, no. 2, pp. 1–9, 2017.
[7] A. D. Theocharis, S. S. Skandalis, C. Gialeli, and N. K. Karamanos, “Extracellular matrix structure,” Adv. Drug Deliv. Rev., vol. 97, pp. 4–27, 2016.
[8] C. Walker, E. Mojares, and A. Del Río Hernández, Role of extracellular matrix in development and cancer progression, vol. 19, no. 10. 2018.
[9] L. Chen, C. Yan, and Z. Zheng, “Functional polymer surfaces for controlling cell behaviors,” Mater. Today, vol. 21, no. 1, pp. 38–59, 2018.
[10] V. M. W. Kumar, Sanjay, “Mechanics, malignancy, and metastasis: The force journey of a tumor cell,” Cancer Metastasis Rev., vol. 28, no. 1, pp. 113–127, 2009.
[11] X. Trepat, Z. Chen, and K. Jacobson, “Cell migration.,” Compr. Physiol., vol. 2, no. 4, pp. 2369–2392, 2012.
[12] G. Kirfel, A. Rigort, B. Borm, and V. Herzog, “Cell migration: Mechanisms of rear detachment and the formation of migration tracks,” Eur. J. Cell Biol., vol. 83, no. 11–12, pp. 717–724, 2004.
[13] and J. P. T. M. Angela Nieto, Ruby Yun-Ju Huang, Rebecca A. Jackson, “EMT:2016,” Cell, vol. 166, no. 1, pp. 21–45, 2016.
[14] P. Friedl, “Prespecification and plasticity: Shifting mechanisms of cell migration,” Curr. Opin. Cell Biol., vol. 16, no. 1, pp. 14–23, 2004.
[15] I. Hecht et al., “Tumor invasion optimization by mesenchymal-amoeboid heterogeneity,” Sci. Rep., vol. 5, pp. 1–12, 2015.
[16] P. Pandya, J. L. Orgaz, and V. Sanz-Moreno, “Actomyosin contractility and collective migration: may the force be with you,” Curr. Opin. Cell Biol., vol. 48, pp. 87–96, 2017.
[17] M. Amano et al., “Phosphorylation and activation of myosin by Rho-associated kinase (Rho- kinase),” J. Biol. Chem., vol. 271, no. 34, pp. 20246–20249, 1996.
[18] V. Sanz-Moreno et al., “Rac activation and inactivation control plasticity of tumor cell movement,” Cell, vol. 135, no. 3, pp. 510–523, 2008.
[19] P. Friedl and S. Alexander, “Cancer invasion and the microenvironment: Plasticity and reciprocity,” Cell, vol. 147, no. 5, pp. 992–1009, 2011.
[20] W. G. Stetler-stevenson, S. Aznavoorian, and A. Liotta, “Tumor cell interactions with the extracellular matrix during invasion and metastasis,” Invasion And Metastasis, vol. 9, no. 5, pp. 41–73, 1993.
[21] P. Van Lint and C. Libert, “Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation,” J. Leukoc. Biol., vol. 82, no. 6, pp. 1375–1381, 2007.
[22] T. E. Cawston and D. A. Young, “Proteinases involved in matrix turnover during cartilage and bone breakdown,” Cell Tissue Res., vol. 339, no. 1, pp. 221–235, 2010.
[23] P. Lu, K. Takai, V. M. Weaver, and Z. Werb, “Extracellular matrix degradation and remodeling in development and disease,” Cold Spring Harb. Perspect. Biol., vol. 3, no. 12, pp. 1–24, 2011.
[24] M. Kapałczyńska et al., “2D and 3D cell cultures – a comparison of different types of cancer cell cultures,” Arch. Med. Sci., vol. 14, no. 4, 2018.
[25] L. B. Weiswald, D. Bellet, and V. Dangles-Marie, “Spherical Cancer Models in Tumor Biology,” Neoplasia (United States), vol. 17, no. 1, pp. 1–15, 2015.
[26] C. Te Kuo, J. Y. Wang, Y. F. Lin, A. M. Wo, B. P. C. Chen, and H. Lee, “Three-dimensional spheroid culture targeting versatile tissue bioassays using a PDMS-based hanging drop array,” Sci. Rep., vol. 7, no. 1, pp. 1–10, 2017.
[27] T. Y. Tu et al., “Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screening,” Adv. Healthc. Mater., vol. 3, no. 4, pp. 609–616, 2014.
[28] D. Kloß, M. Fischer, A. Rothermel, J. C. Simon, and A. A. Robitzki, “Drug testing on 3D in vitro tissues trapped on a microcavity chip,” Lab Chip, vol. 8, no. 6, pp. 879–884, 2008.
[29] P. Zorlutuna et al., “Microfabricated biomaterials for engineering 3D tissues,” Adv. Mater., vol. 24, no. 14, pp. 1782–1804, 2012.
[30] S. Kumar, A. Das, and S. Sen, “Multicompartment cell-based modeling of confined migration: regulation by cell intrinsic and extrinsic factors,” Mol. Biol. Cell, vol. 29, no. 13, pp. 1599–1610, 2018.
[31] A. R. and S. Kumar, “A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces,” Biomaterials, vol. 35, no. 31, pp. 8846–8853, 2014.
[32] E. George, A. Barai, P. Shirke, A. Majumder, and S. Sen, “Engineering interfacial migration by collective tuning of adhesion anisotropy and stiffness,” Acta Biomater., vol. 72, pp. 82–93, 2018.
[33] S. R. Unnikandam Veettil, S. M. Van Bruggen, D. G. Hwang, M. D. Bartlett, and I. C. Schneider, “Tuning surface functionalization and collagen gel thickness to regulate cancer cell migration,” Colloids Surfaces B Biointerfaces, vol. 179, no. September 2018, pp. 37–47, 2019.
[34] Z. Qian, D. Ross, W. Jia, Q. Xing, and F. Zhao, “Bioactive polydimethylsiloxane surface for optimal human mesenchymal stem cell sheet culture,” Bioact. Mater., vol. 3, no. 2, pp. 167–173, 2018.
[35] E. Mussig et al., “Connective-tissue fibroblasts established on micropillar interfaces are pivotal for epithelial-tissue morphogenesis,” Adv. Funct. Mater., vol. 18, no. 19, pp. 2919–2929, 2008.
[36] C. D. James et al., “Aligned microcontact printing of micrometer-scale poly-L-lysine structures for controlled growth of cultured neurons on planar microelectrode arrays,” IEEE Trans. Biomed. Eng., vol. 47, no. 1, pp. 17–21, 2000.
[37] S. Chung, R. Sudo, I. K. Zervantonakis, T. Rimchala, and R. D. Kamm, “Surface-Treatment-Induced Three-Dimensional Capillary Morphogenesis in a Microfluidic Platform,” Adv. Mater., vol. 21, no. 47, pp. 4863–4867, 2009.
[38] and S. C. Yoojin Shin, Sewoon Han, Jessie S. Jeon, Kyoko Yamamoto, Ioannis K. Zervantonakis, Ryo Sudo, Roger D. Kamm, “Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels,” Nat Protoc., vol. 7, no. 7, pp. 1247–1259, 2012.
[39] S. Kuddannaya, Y. J. Chuah, M. H. A. Lee, N. V. Menon, Y. Kang, and Y. Zhang, “Surface chemical modification of poly(dimethylsiloxane) for the enhanced adhesion and proliferation of mesenchymal stem cells,” ACS Appl. Mater. Interfaces, vol. 5, no. 19, pp. 9777–9784, 2013.
[40] Y. Chang, C. C. Tsai, H. C. Liang, and H. W. Sung, “Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in a canine model,” J. Thorac. Cardiovasc. Surg., vol. 122, no. 6, pp. 1208–1218, 2001.
[41] H. Nagaoka et al., “Characterization of genipin-modified dentin collagen,” Biomed Res. Int., vol. 2014, 2014.
[42] G. G. Genchi et al., “Bio/non-bio interfaces: A straightforward method for obtaining long term PDMS/muscle cell biohybrid constructs,” Colloids Surfaces B Biointerfaces, vol. 105, pp. 144–151, 2013.
[43] M. Hecker, M. S. H. Ting, and J. Malmström, “Simple coatings to render polystyrene protein resistant,” Coatings, vol. 8, no. 2, pp. 1–13, 2018.
[44] A. Doyle, “Fluorescent Labeling of Rat-tail Collagen for 3D Fluorescence Imaging,” Bio-Protocol, vol. 8, no. 13, 2018.
[45] M. Rojkind, M. A. Giambrone, and L. Biempica, “Collagen Types in Normal and Cirrhotic Liver,” Gastroenterology, vol. 76, no. 4, pp. 710–719, 1979.
[46] E. J. Mah, G. E. McGahey, A. F. Yee, and M. A. Digman, “Collagen stiffness modulates MDA-MB-231 cell metabolism through adhesion-mediated ontractility,” SSRN Electron. J., pp. 1–33, 2018.
[47] O. Mendes, H. T. Kim, and G. Stoica, “Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model,” Clin. Exp. Metastasis, vol. 22, no. 3, pp. 237–246, 2005.
[48] D. E. Discher, P. Janmey, and Y. L. Wang, “Tissue cells feel and respond to the stiffness of their substrate,” Science (80-. )., vol. 310, no. 5751, pp. 1139–1143, 2005.
[49] S. Van Helvert, C. Storm, and P. Friedl, “Mechanoreciprocity in cell migration,” Nat. Cell Biol., vol. 20, no. 1, pp. 8–20, 2018.
[50] I. J. Gomez, B. Arnaiz, M. Cacioppo, F. Arcudi, and M. Prato, “Matrix stiffness-regulated cell functions under different dimensionalities,” J. Mater. Chem. B, vol. 6, no. 35, 2018.
[51] G. Walko, M. J. Castañón, and G. Wiche, “Molecular architecture and function of the hemidesmosome,” Cell Tissue Res., vol. 360, no. 3, pp. 529–544, 2015.
[52] C. Preethi L., P. David C., and H. Jeffrey W., “Structural mechanism for alteration of collagen gel mechanics by glutaraldehyde crosslinking,” Connect. Tissue Res., vol. 53, no. 4, pp. 1–23, 2013.